WallStreetZenWallStreetZen

NASDAQ: ANIP
Ani Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Ani Pharmaceuticals earnings were $108.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ANIP earnings report on Jun 30, 2026 announced Q2 2026 earnings of $24.7M, down 16.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ANIP reported annual earnings of $77.2M, with -483.1% growth. The next ANIP earnings date is Nov 6, 2026.

ANIP past earnings growth

How has ANIP's earnings growth performed historically?

Company
N/A
Industry
101.99%
Market
92.82%
ANIP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ANIP's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

ANIP earnings history

Current Revenue
$978.4M
Current Earnings
$108.0M
Current Profit Margin
11%
ANIP's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ANIP Return on Equity

Current Company
19.6%
Current Industry
1.8%
Current Market
30.9%
ANIP's Return on Equity (19.6%)... subscribe to Premium to read more.
High Return on Equity Performance

ANIP Return on Assets

Current Company
7.5%
Current Industry
3.9%
ANIP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ANIP announces earnings.

ANIP Return on Capital Employed

Current Company
13.15%
Current Industry
9.6%
ANIP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ANIP vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ANIP$246.77M$107.97M+102.32%$4.83
ETON$20.91M$12.69MN/A$0.47
ALVO$167.98M-$179.59MN/A-$0.62
PRGO-$1.13B-$1.73BN/A-$12.52
PAHC$233.29M$99.72M+12.92%$2.46
View Top Pharmaceutical Stocks

ANIP earnings dates

Next earnings date
Nov 6, 2026

Ani Pharmaceuticals Earnings Reports & History FAQ

What were Ani Pharmaceuticals's earnings last quarter?

On ANIP's earnings call on Aug 7, 2026, Ani Pharmaceuticals (NASDAQ: ANIP) reported Q2 2026 earnings per share (EPS) of $1.09, up 194.59% year over year. Total ANIP earnings for the quarter were $24.71 million. In the same quarter last year, Ani Pharmaceuticals's earnings per share (EPS) was $0.37.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.

When does Ani Pharmaceuticals report earnings?

The next ANIP earnings call is Nov 6, 2026. Add ANIP to your watchlist to be reminded of Ani Pharmaceuticals's next earnings date.

Is Ani Pharmaceuticals profitable or losing money?

As of the last Ani Pharmaceuticals earnings report, Ani Pharmaceuticals is currently profitable. Ani Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $108.31 million, a 1,160.61% decrease year over year.

What was ANIP's earnings growth in the past year?

As of Ani Pharmaceuticals's earnings date in Aug 7, 2026, Ani Pharmaceuticals's earnings has grown year over year. ANIP earnings in the past year totalled $107.97 million.

What are Ani Pharmaceuticals's earnings expectations?

The current EPS estimate for Ani Pharmaceuticals's earnings report in Nov 6, 2026 is $1.77.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.